CBER Anthrax Vaccine Development: Licensable Product Anticipated In 2003
Executive Summary
The Laboratory of Enteric & Sexually Transmitted Diseases in FDA's Center for Biologics Evaluation & Research expects to create a licensable anthrax vaccine by summer 2003